Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 118.3B | 98.2B | 100.5B |
Cost of revenue | — | 69.0B | 55.7B | 56.0B |
Gross profit | — | 49.2B | 42.5B | 44.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 33.1B | 29.6B | 29.3B |
Other operating expenses | — | 891M | 159M | 331M |
Operating income | — | 16.3B | 13.0B | 15.2B |
Non operating interest income | ||||
Income | — | 2.3B | 1.0B | 874M |
Expense | — | 1.3B | 1.7B | 964M |
Other income expense | — | — | — | — |
Pretax income | — | 17.3B | 12.4B | 15.2B |
Tax provision | — | 4.6B | 4.1B | 4.8B |
Net income | — | 12.7B | 8.3B | 10.5B |
Basic EPS | 19.5 | — | 24.3 | 30.2 |
Diluted EPS | 19.5 | — | 24.3 | 30.2 |
Basic average shares | 334.1M | — | 339.5M | 344.0M |
Diluted average shares | 334.1M | — | 339.5M | 344.0M |
EBITDA | — | 23.1B | 18.7B | 20.8B |
Net income from continuing op. | — | 17.3B | 12.4B | 15.2B |
Minority interests | — | -43M | -44M | -61M |
Preferred stock dividends | — | 0 | 0 | 0 |